FDA approves treatment for people with mild forms of Alzheimer’s
January 06, 2023 at 14:47 PM EST
Leqembi, which was developed by Eisai and Biogen, will cost about $26,000 a year
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|